Shaji Kumar, MD, discusses how clinicians are navigating the evolving landscape of multiple myeloma treatment, from considering early intervention in high-risk smoldering cases to personalizing ...

the National Comprehensive Cancer Network (NCCN) guidelines for treating multiple myeloma recommend Pomalyst as a treatment option in adults with multiple myeloma who meet the above criteria.

Patients with multiple myeloma (MM) can experience diminished immune responses during prolonged treatment; however, mRNA vaccines could bolster immunity in this vulnerable population. The 66th ...

Sarclisa was added to the National Comprehensive Cancer Network (NCCN) guidelines for non-transplant multiple myeloma candidates as a category 1 (preferred) option alongside VRd and Darzalex plus ...